Piergiorgio Pedron - DiaSorin SpA Senior Corporate VP and CFO
| DSRLF Stock | USD 106.85 0.32 0.30% |
CFO
Mr. Piergiorgio Pedron has served as Senior Corporationrationrate VP and Chief Financial Officer at DiaSorin S.p.A. since April 28, 2016. He graduated summa cum laude in Economics from the Universita Cattolica del Sacro Cuore, Milano. In 2011, he joined DiaSorin S.p.A. as Group Controller, Corporationrationrate Vice President. Later he served as CFO at the North American subsidiary DiaSorin Inc for 18 months. In January 2015, he came back to Italy assuming the role of Deputy Chief Financial Officer at DiaSorin S.p.A. Previously he served as Controller for multinational companies Jabil and Hewlett Packard in North America and for De Agostini Editore S.p.A. where he held the position of Group Controller at the UK branch for 2 years. since 2016.
| Age | 52 |
| Tenure | 8 years |
| Phone | 39 01 614871 |
| Web | https://diasoringroup.com |
DiaSorin SpA Management Efficiency
The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | CFO Age | ||
| Shawn Vadala | Mettler Toledo International | 55 | |
| Jonathan Lyons | Sotera Health Co | 46 | |
| Michael Silveira | Waters | 53 | |
| Robert CMA | Agilent Technologies | 55 | |
| Maxwell Krakowiak | Revvity | 34 | |
| Brian McKeon | IDEXX Laboratories | 62 | |
| Brendan Brennan | ICON PLC | 45 | |
Management Performance
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 |
DiaSorin SpA Leadership Team
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fabrizio Bonelli, Chief Officer | ||
| Carlo Rosa, CEO, General Manager and Executive Director | ||
| Piergiorgio Pedron, Senior Corporate VP and CFO | ||
| Ulisse Spada, Mang Department | ||
| Angelo Rago, Pres Corp | ||
| Stefano Ronchi, Sr. Corporate VP of HR | ||
| Ugo Gay, Sr Operations | ||
| Chen Even, Chief Commercial Officer and Executive Director | ||
| Riccardo Fava, Director of Investor Relations and Corporate Communication |
DiaSorin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 57.50 % | |||
| Shares Owned By Institutions | 22.36 % | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X |
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.